CARBOPOL 974 PDF

The study of Carbopol P as a microbicide for preventing HIV infection was discontinued. Data from a Phase II/IIb study demonstrated that Carbopol P. Drug information on Carbopol P for patients and consumers. Drug information on Carbopol P for health care professionals.

Author: Mikalkree Dukasa
Country: Singapore
Language: English (Spanish)
Genre: Literature
Published (Last): 12 March 2015
Pages: 83
PDF File Size: 2.13 Mb
ePub File Size: 8.48 Mb
ISBN: 440-9-29784-515-2
Downloads: 54695
Price: Free* [*Free Regsitration Required]
Uploader: Yozshusho

The risk or severity of thromboembolism can be increased when Carbopol P is combined with Conestat alfa. Mucoadhesivity is a desired property for the delivery of drugs to mucosal tissues. Ifosfamide The metabolism of Carbopol P can be increased when combined with Ifosfamide.

Enzalutamide The metabolism of Carbopol P can be increased when combined with Enzalutamide. In the case of release from the surface, particulate and adsorbed drug dissolves rapidly and it leads to burst effect when it comes in contact with the release medium [ 5 ].

Etravirine The metabolism of Carbopol P can be increased when combined with Etravirine. Rofecoxib The metabolism of Carbopol P can be increased when combined with Rofecoxib.

The risk or severity of adverse effects can be increased when Carbopol P is combined with Flibanserin. Prednylidene The serum concentration of Prednylidene can be increased when it is combined with Carbopol P. Tranexamic acid Carbopol P may increase the thrombogenic activities of Tranexamic Acid.

Functional Performance of Chitosan/Carbopol P NF Matrices in Captopril Tablets

The therapeutic efficacy of Dabigatran can be increased when used in combination with Carbopol P. Ivosidenib The metabolism of Carbopol P can be increased when combined with Ivosidenib. Fluocortolone The serum concentration of Fluocortolone can be increased when it is combined with Carbopol P. The compressibility index values stand for a chitosan powder flowability only two times greater than that of Carbopol P NF.

The serum concentration of Melengestrol can be increased when it is combined with Carbopol P. Cloprednol The serum concentration of Cloprednol can be increased when it is combined with Carbopol P.

Subscribe to Table of Contents Alerts. Powder flow rate through an orifice of 8. Bosentan The serum concentration of Carbopol P can be decreased when it is combined with Bosentan. The therapeutic efficacy of Alteplase can be increased when used in combination with Carbopol P. Acenocoumarol The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Carbopol P. The serum concentration of Carbopol P can be decreased when it is combined with Clomocycline.

  DESCARGAR LIBRO SOL DE MEDIANOCHE DE STEPHENIE MEYER PDF

Contrasting, increasing proportions of Carbopol P NF in the powder mixtures decrease their flowability. Figure 2 depicts the effect of Carbopol P NF, chitosan, and the mixture thereof on the powder flow rate of captopril mixtures containing different polymer proportions.

Journal of Pharmaceutics

Captopril mixtures containing different proportions of the combination of the two polymers show a similar trend to that observed before by the measurement of the powder flow rate of mixtures containing only Carbopol P NF.

Penamecillin The metabolism of Carbopol P can be increased when combined with Penamecillin. Telaprevir The serum concentration of Carbopol P can be decreased when it is combined with Telaprevir. Matrix system is the most widely used method for development of controlled release formulations due to its easy of manufacture.

Rifabutin The metabolism of Carbopol P can be increased when combined with Rifabutin. Fondaparinux The therapeutic efficacy of Fondaparinux can be increased when used in combination with Carbopol P.

Effect of polymer proportion on the powder flow rate of admixtures with captopril, through a funnel with an opening of 8. Carbopol produces metronidazole tablets with a crushing strength 3 times greater than tablets with the same proportion of hydroxypropyl methylcellulose [ 22 ]. Formestane The metabolism of Carbopol P can be increased when combined with Formestane.

Carbopol P – DrugBank

Figure 5 shows the compressibility index of captopril powder mixtures with different proportions of chitosan, Carbopol P NF, and the mixture thereof. Ciclosporin The metabolism of Carbopol P can be increased when combined with Cyclosporine.

Nafamostat The therapeutic efficacy of Nafamostat can be increased when used in combination with Carbopol P.

The therapeutic efficacy of Danaparoid can be increased when used in combination with Carbopol P. Acetylsalicylic acid The therapeutic efficacy of Acetylsalicylic acid can be increased when used in combination with Carbopol P.

Elvitegravir The serum concentration of Carbopol P can be decreased when it is combined with Elvitegravir. Fosaprepitant The metabolism of Ccarbopol P can be increased when combined with Fosaprepitant.

  CPD ONLINE 692 509 PDF

Characterization of the functional performance of pharmaceutical excipients can not only be considered as a requirement but also provide data that can be predictive in nature regarding the performance of final dosage forms.

Iloprost The therapeutic efficacy of Iloprost can be increased when used in combination with Carbopol P. Vorapaxar The therapeutic efficacy of Vorapaxar can be increased when used in combination with Carbopol P.

Estradiol valerate The metabolism of Carbopol P can be increased when combined with Estradiol valerate. Melengestrol The serum concentration of Melengestrol can be increased when it is combined with Carbopol P.

Defibrotide The therapeutic efficacy of Defibrotide can be increased when used in combination with Carbopol P. Testosterone cypionate The metabolism of Carbopol P can be increased when combined with Testosterone cypionate. The influence of different proportions of chitosan on captopril compactibility is not appreciable.

Danaparoid The therapeutic efficacy of Danaparoid can be increased when used in combination with Carbopol P. The serum concentration of Methylprednisolone aceponate can be increased when it is combined with Carbopol P. Gabexate The therapeutic efficacy of Gabexate can be increased when used in combination with Carbopol P.

This occurs in the same way as observed before in a direct measurement of the powder flow rate Figure 2. The therapeutic efficacy of Tocopherylquinone can be increased when used in combination with Carbopol P. Hydrocortisone succinate The metabolism of Carbopol P can be increased when combined with Hydrocortisone succinate. Cortisone The serum concentration of Cortisone can be increased when it is combined with Carbopol P.

At pH exceeding 6. The observed technological behavior points out to a greater interaction between the particles of polymers with different charge than between particles of the individual polymers.